| SPIRIT 2013 statement: defining standard protocol items for clinical trials AW Chan, JM Tetzlaff, DG Altman, A Laupacis, PC Gøtzsche, ... Annals of internal medicine 158 (3), 200-207, 2013 | 5852 | 2013 |
| SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials AW Chan, JM Tetzlaff, PC Gøtzsche, DG Altman, H Mann, JA Berlin, ... Bmj 346, 2013 | 4784 | 2013 |
| The national lung screening trial: overview and study design National Lung Screening Trial Research Team Radiology 258 (1), 243-253, 2011 | 1313 | 2011 |
| SPIRIT 2013 Statement: defining standard protocol items for clinical trials AW Chan, JM Tetzlaff, DG Altman, A Laupacis, PC Gøtzsche, ... Revista Panamericana de Salud Pública 38, 506-514, 2015 | 298* | 2015 |
| A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation CCTWGRG Barr, EA Berkowitz, F Bigazzi, F Bode, J Bon, RP Bowler, ... COPD: Journal of Chronic Obstructive Pulmonary Disease 9 (2), 151-159, 2012 | 167 | 2012 |
| Imaging findings of vaping-associated lung injury TS Henry, SJ Kligerman, CA Raptis, H Mann, JW Sechrist, JP Kanne American Journal of Roentgenology 214 (3), 498-505, 2020 | 128 | 2020 |
| Research ethics committees and public dissemination of clinical trial results H Mann The Lancet 360 (9330), 406-408, 2002 | 105 | 2002 |
| Clinical, bronchoscopic, and imaging findings of e-cigarette, or vaping, product use–associated lung injury among patients treated at an academic medical center SK Aberegg, MM Cirulis, SD Maddock, A Freeman, LM Keenan, ... JAMA Network Open 3 (11), e2019176-e2019176, 2020 | 64 | 2020 |
| Choosing a control intervention for a randomised clinical trial H Mann, B Djulbegovic BMC Medical Research Methodology 3, 1-5, 2003 | 61 | 2003 |
| Effects of improved contrast on lung-nodule detection A clinical ROC study JA SORENSON, CR MITCHELL, II JOHN D ARMSTRONG, H MANN, ... Investigative radiology 22 (10), 772-780, 1987 | 45 | 1987 |
| Comparator bias: why comparisons must address genuine uncertainties H Mann, B Djulbegovic Journal of the Royal Society of Medicine 106 (1), 30-33, 2013 | 39 | 2013 |
| Vascular leak syndrome associated with interleukin-2: chest radiographic manifestations. H Mann, JH Ward, WE Samlowski Radiology 176 (1), 191-194, 1990 | 37 | 1990 |
| Radiographic differentiation between different etiologies of pulmonary edema RC Smith, H Mann, RH Greenspan, CF Pope, HD Sostman Investigative Radiology 22 (11), 859-863, 1987 | 31 | 1987 |
| Identifying the human research subject in cluster randomized controlled trials H Mann, M Reyes IRB: Ethics & Human Research 30 (5), 14-18, 2008 | 17 | 2008 |
| The organization and technique of group treatment of psychoses J Mann, H Mann Diseases of the nervous system 9 (2), 46-51, 1948 | 15 | 1948 |
| SPIRIT 2013 Bildirisi: Klinik Deneyler İçin Standart Protokol Maddelerinin Tanımlanması. AW Chan, JM Tetzlaff, DG Altman, A Laupacis, PC Gøtzsche, ... Journal of Hacettepe University Faculty of Nursing 8 (1), 2021 | 14 | 2021 |
| SPIRIT 2013 statement: Defining standard protocol items for clinical trials AW Chan Japanese Pharmacology and Therapeutics (Drugs and Treatments) 45 (12), 1895, 2017 | 14 | 2017 |
| Controversial choice of a control intervention in a trial of ventilator therapy in ARDS: standard of care arguments in a randomised controlled trial H Mann Journal of medical ethics 31 (9), 548-553, 2005 | 13 | 2005 |
| Smoke: how to differentiate flow-related artifacts from pathology on thoracic computed tomographic angiography TS Henry, MM Hammer, BP Little, LE Jensen, SJ Kligerman, JP Kanne, ... Journal of Thoracic Imaging 34 (5), W109-W120, 2019 | 12 | 2019 |
| Equipoise in the enhanced supression of the platelet IIb/IIIa receptor with integrilin trial (ESPRIT): a critical appraisal H Mann, AJ London, J Mann Clinical Trials 2 (3), 233-243, 2005 | 12 | 2005 |
